Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb. [1] Biography. Early life. Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti.

    • Business executive
    • Giulio Andreotti (father), Livia Danese (mother)
    • 6 July 1950 (age 73), Rome, Italy
  2. Lamberto Andreotti. Mr. Andreotti is the former chairman of the board and chief executive officer of Bristol-Myers Squibb Company, a global, innovative healthcare company. He served as chairman at Bristol-Myers Squibb from May 2015 to May 2017 and chief executive officer from May 2010 to May 2015. Mr.

  3. Dal pharma alle banche, ecco perché Lamberto Andreotti è diventato una figura chiave per il futuro di Unicredit. di Luca Gualtieri. Scelto da Mustier e confermato da Orcel, il vice presidente ha sempre preservato l’equidistanza dai ceo ed è il punto di riferimento di molti investitori internazionali. Che Unicredit sia la più ...

  4. 2. März 2010 · NEW YORK-- (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that Lamberto Andreotti, 59, has been designated by the Board of Directors to serve as the company's chief...

  5. Retired Chairman & CEO Bristol-Myers Squibb · Experience: Bristol-Myers Squibb · Location: New York · 199 connections on LinkedIn. View Lamberto Andreottis profile on LinkedIn, a ...

    • 191
    • May 1, 2017
    • Bristol-Myers Squibb
    • New York, New York, United States
  6. 30. März 2024 · Lamberto Andreotti: Positions, Relations and Network - MarketScreener. Director/Board Member at UNICREDIT S.P.A. Net worth: 2 M $ as of 2024-03-30. 73 year. 100 connections. Health Technology. Process Industries. Finance. Summary. Experience. Personal Network. Company connections. Profile.

  7. 21. Jan. 2015 · Bristol-Myers Squibb (BMS) CEO Lamberto Andreotti will be succeeded in May by the company’s COO, Giovanni Caforio, M.D., the company said, as Andreotti moves on to become executive chairman—a...